Sharenet Sites 
Sharenet Sites
Trading statement – Group results for the year ended 31 March 2015
MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1983/010725/06
ISIN: ZAE000074142
JSE Share Code: MDC
NSX Share Code: MCI
("Mediclinic" or "the Company")
TRADING STATEMENT – GROUP RESULTS FOR THE YEAR ENDED 31 MARCH 2015
In terms of the JSE Limited ("JSE") Listings Requirements,
companies are required to publish a trading statement as soon as
they are satisfied that a reasonable degree of certainty exists
that the financial results for the period to be reported upon next
will differ by at least 20% from that of the previous
corresponding reporting period. Mediclinic is in the process of
finalising its year-end results for the twelve months ended 31
March 2015, which are due to be released on SENS on 21 May 2015
and published in the press on 22 May 2015 ("year-end results
announcement").
Accordingly, shareholders are advised that the Company’s basic
earnings per share ("EPS") for the year ended 31 March 2015 are
expected to be between 83.4 and 104.2 cents, or 20% and 25% higher
than the restated 416.8 cents reported for the year ended 31 March
2014 ("the previous period"). The Company’s basic EPS, basic
headline earnings per share ("HEPS") and normalised HEPS for the
previous period were adjusted in terms of IAS 33 paragraph 26 and
released on SENS on 6 November 2014.
In order to provide clear and meaningful guidance to shareholders,
this trading statement will also address basic HEPS and normalised
HEPS. Normalised HEPS are defined as reportable HEPS in terms of
accounting standards, excluding one-off and exceptional items.
Details of one-off and exceptional items will be provided in the
year-end results announcement.
The Company’s basic HEPS for the year ended 31 March 2015 are
expected to be between 62.0 and 82.6 cents, or 15% and 20% higher
than the 413.1 cents reported for the previous period. Excluding
the one-off and exceptional items, basic normalised HEPS are
expected to be between 30.1 and 37.6 cents, or 8% and 10% higher
than the 375.8 cents reported for the previous period.
The financial information on which this trading statement is based
has not been reviewed and reported on by the Company’s external
auditors.
Stellenbosch
13 May 2015
Mediclinic Offices, Strand Road, Stellenbosch 7600
PO Box 456, Stellenbosch 7599
Tel +27 21 809 6500
Fax +27 21 886 4037
Ethics line: 0800 005 316 (if dialling from South Africa) or
ethics@mediclinic.com
Website: www.mediclinic.com
Sponsor
South Africa: Rand Merchant Bank (a division of FirstRand Bank
Limited)
Namibia: Simonis Storm Securities (Proprietary) Limited
Date: 13/05/2015 07:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
